Engineering the Future of Radiotherapy: Innovations and Challenges

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 37

Special Issue Editors


E-Mail Website
Guest Editor
2nd Department of Radiology, Medical Physics Unit (Attikon Hospital), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Interests: medical physics in radiation oncology; stereotactic radiotherapy; TSEB; dosimetry; modern techniques and quality assurance in radiotherapy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
2nd Department of Radiology, Radiation Oncology Unit (Attikon Hospital), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Interests: radiation oncology; bioengineering; stereotactic radiotherapy; radiobiology; quality assurance in radiotherapy; modern techniques
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Nowadays, radiation therapy (RT) has shown tremendous evolution in terms of technological achievements and novel techniques. Stereotactic radiosurgery and proton therapy have demonstrated excellent results by minimizing toxicity, while new image-guided techniques (IGRTs), such as surface-guided RT (SGRT) or MRI-based IGRT through MR-Linacs, have already been adopted worldwide. The new promising treatment of “flash” RT seems quite promising for minimizing toxicity.

The combination of nanoparticles (NPs) and RT opens up a new frontier in cancer treatment.

NPs can be used as contrast enhancement in IGRT and may lead to an increased local radiation dose by using particles with higher atomic numbers (Z). The various roles of NPs as radiosensitizers in radiotherapy may provide new directions for optimization and radiotherapy efficacy.

The introduction of AI in the routine clinical practice of radiation oncology focuses on two main goals. The first goal is to improve efficiency, mainly through automation, while the second is to provide predictive tools for the better personalization of treatment. Deep learning models are used for automatic delineation and the segmentation of tumors and organs at risk. AI has also been utilized in treatment planning and optimization. Knowledge-based treatment planning and deep learning techniques have been employed to produce treatment plans comparable to those generated by humans. Additionally, AI has potential applications in adaptive radiotherapy, in the quality control and assurance of treatment plans, the optimization of image-guided RT, and the monitoring of mobile tumors during treatment.

All innovations are driving the RT in the “era of excellence” in anticancer treatment, undertaking the challenge of developing more sophisticated and tailored RT.

Dr. Kalliopi Platoni
Dr. Vassilis Kouloulias
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiosurgery
  • stereotactic radiotherapy
  • proton therapy
  • artificial intelligence (AI)
  • flash therapy
  • image/surface-guided radiotherapy
  • nanoparticles

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop